Aphria Inc. APHA

Aphria, which is headquartered in Ontario, produces and sells medicinal and recreational cannabis. The company operates through retail and wholesale channels in Canada and internationally. Aphria is a main distributor of medical cannabis to Germany and has operations in over 10 countries outside of Canada. However, it does not have exposure to the U.S. CBD or THC markets due to the constraints of federal prohibition. It has some U.S. exposure through the acquisition of SweetWater, a craft brewer

NDAQ:APHA - Post by User

Aphria Inc. > Q1-Q2 2021 Cashflow positive?

<< Previous

Bullboard Posts

Next >>

Comment by gottahunchon Sep 26, 2020 5:19pm

166 Views

Post# 31625746

RE:RE:RE:RE:Q1-Q2 2021 Cashflow positive?

Thanks @CentreIce24 for that

CentreIce24 wrote: Hey DD64
From the Aphria's MD&A in July

Aleafia Settlement Subsequent to year-end, we entered into a settlement agreement with Aleafia Health Inc. (“Aleafia”) with respect to the settlement of the arbitration relating to the Supply Agreement between the parties. As part of the settlement, Aleafia received total consideration of approximately $29,000 comprised of $15,500 cash and $10,000 worth of common shares of the Company with the balance consisting of the waiver of accounts receivable owed by Aleafia to Aphria. The Company recorded a loss of $4,345 on settlement, based on the consideration paid of $25,500, forgiveness of $3,101 of accounts receivable, offset by deferred revenue of $22,756, and accounts payable and accrued liabilities of $1,500. The full amount has been provided for in the year and recorded in accounts payable and accrued liabilities.

Daredevil1964 wrote: Unortunatly Q4 ended ended May 31 of 2020. The Aleafia transaction will have a bearing on the upcoming quarter, Exactly how is anyone's guess. How Aphria, and where Aphria includes the settlement is key. Revenue will not be affected but, the EPS certainly could be.